Tren burns fat even when bulking.... full explination video

[RyanGreg]

http://www.youtube.com/watch?feature...&v=AS5tmscUmkM

[marcus300]

Is that voice for real hahahaa

[RyanGreg]

Is that voice for real hahahaa

lol!

what do you think about what he said in the video though marcus? whats your opinion on it?

[t-dogg]

Ive seen this before and yes I believe its true.

[Thunderforge]

I don't know what to make of it. My experience with the compound was positive but limited as well.

Speaking purely from a debate standpoint. It's just a bunch of talk. Like most of the Internet there's no sources listed for the information. He can say "Cattle gained 100 pounds in a month but lost too much fat" or he can say the gained 1000 pounds of muscle, it doesn't mean anything to me unless he cites some article, study, something that the viewer can reference.

Mind you, I'm not refuting Trens properties. Just keep things in perspective. It's easy to get all excited about incredible claims but in the end, this is just some guy talking.

[MR10X]

17β-hydroxyestra-4,9,11-trien-3-one (trenbolone ) is a potent synthetic testosterone analogue which does not undergo 5α reduction to more potent metabolites (46). As such, trenbolone may induce less growth in prostate and other androgenic tissues which highly express 5α reductase. This is in contrast to testosterone, which has approximately three fold greater potency in androgenic tissues, which highly express 5α reductase (63), due to its conversion to dihydrotestosterone (DHT).

The primary purpose of this study was to determine the effects of trenbolone-enanthate (TREN ; a slowly released trenbolone ester) on a variety of androgen sensitive tissues, including skeletal muscle, bone, visceral adiposity, hemoglobin, and the prostate of rodents. Because trenbolone is selectively metabolized to weaker androgens in vivo, they hypothesized that TREN will produce dose-dependent anabolic effects in skeletal muscle, bone, and fat that are at least equal to those of supraphysiological testosterone, while producing a smaller increase in hemoglobin and less growth of the prostate. Their findings indicate that TREN has advantages over supraphysiologic testosterone and supports the need for future pre-clinical studies examining the viability of TREN as an option for androgen replacement therapy.


Yarrow JF, Conover CF, McCoy SC, et al. 17β-hydroxyestra-4,9,11-trien-3-one (Trenbolone) Exhibits Tissue Selective Anabolic Activity: Effects on Muscle, Bone, Adiposity, Hemoglobin, and Prostate. American Journal of Physiology - Endocrinology And Metabolism. 17β-hydroxyestra-4,9,11-trien-3-one (Trenbolone) Exhibits Tissue Selective Anabolic Activity: Effects on Muscle, Bone, Adiposity, Hemoglobin, and Prostate — AJP - Endo

Selective androgen receptor modulators (SARMs ) now under development can protect against muscle and bone loss, without causing prostate growth or polycythemia. 17β-hydroxyestra-4,9,11-trien-3-one (trenbolone), a potent testosterone analogue, may have SARM-like actions because, unlike testosterone, trenbolone does not undergo tissue-specific 5α reduction to form more potent androgens. We tested the hypothesis that trenbolone-enanthate (TREN) might prevent orchiectomy-induced losses in muscle and bone and visceral fat accumulation, without increasing prostate mass or resulting in adverse hemoglobin elevations.

Male F344 rats aged three months underwent orchiectomy or remained intact and were administered graded doses of TREN, supraphysiologic testosterone-enanthate, or vehicle for 29 days. In both intact and orchiectomized animals, all TREN doses and supraphysiologic testosterone-enanthate augmented androgen-sensitive levator ani/bulbocavernosus muscle mass by 35-40% above Shams (p≤0.001), and produced a dose-dependent partial protection against orchiectomy-induced total and trabecular bone mineral density losses (p<0.05) and visceral fat accumulation (p<0.05). The lowest doses of TREN successfully maintained prostate mass and hemoglobin concentrations at Sham levels in both intact and orchiectomized animals; whereas supraphysiologic testosterone-enanthate and high-dose TREN elevated prostate mass by 84% and 68%, respectively (p<0.01).

In summary, low dose administration of the non-5α reducible androgen TREN maintains prostate mass and hemoglobin concentrations near the level of Shams, while producing potent myotrophic actions in skeletal muscle and partial protection against orchiectomy-induced bone loss and visceral fat accumulation. Our findings indicate that TREN has advantages over supraphysiologic testosterone and supports the need for future pre-clinical studies examining the viability of TREN as an option for androgen replacement therapy.

[austinite]

The guy is pretty much on point.

[fit2bOld]

So what happened you abandoned your las thread about getting your pro card.
All the guys want to see some pics.
Thanks for at least sharing something you didn't make up.

[panntastic]

So what happened you abandoned your las thread about getting your pro card.
All the guys want to see some pics.
Thanks for at least sharing something you didn't make up.

Lol I was waiting for that

[t-dogg]

So what happened you abandoned your las thread about getting your pro card.
All the guys want to see some pics.
Thanks for at least sharing something you didn't make up.

Lolz

[iSwanson]

So what happened you abandoned your las thread about getting your pro card.
All the guys want to see some pics.
Thanks for at least sharing something you didn't make up.

I don't think I've seen a thread that this guy made that someone didn't call him out about a pro card LOL.

[ChiveOn]

The dude in this video really needs to blow his nose or something.... Just can't take it seriously. "The benefits are uuuuge"

[Drahcir_snave]

The dude in this video really needs to blow his nose or something.... Just can't take it seriously. "The benefits are uuuuge"

Lol seriously

Age 25 height 6ft weight 203 bf 13% experience n00b

[copaaz]

what a fag!

[songdog]

You guys are so mean

[ChiveOn]

So what happened you abandoned your las thread about getting your pro card.
All the guys want to see some pics.
Thanks for at least sharing something you didn't make up.

May as well start a new username bro you'll never live this down ahahaha

[Euroholic]

Ryangreg=sickbeard

[crazy mike]

Ryangreg=sickbeard

Haven't heard you in a few, your avi says 23 and I was told you are 18. Are you 18 or 23 ? ...cm

[magic32]

The guy is pretty much on point.

Seconded!

[RyanGreg]

17β-hydroxyestra-4,9,11-trien-3-one (trenbolone ) is a potent synthetic testosterone analogue which does not undergo 5α reduction to more potent metabolites (46). As such, trenbolone may induce less growth in prostate and other androgenic tissues which highly express 5α reductase. This is in contrast to testosterone, which has approximately three fold greater potency in androgenic tissues, which highly express 5α reductase (63), due to its conversion to dihydrotestosterone (DHT).

The primary purpose of this study was to determine the effects of trenbolone-enanthate (TREN ; a slowly released trenbolone ester) on a variety of androgen sensitive tissues, including skeletal muscle, bone, visceral adiposity, hemoglobin, and the prostate of rodents. Because trenbolone is selectively metabolized to weaker androgens in vivo, they hypothesized that TREN will produce dose-dependent anabolic effects in skeletal muscle, bone, and fat that are at least equal to those of supraphysiological testosterone, while producing a smaller increase in hemoglobin and less growth of the prostate. Their findings indicate that TREN has advantages over supraphysiologic testosterone and supports the need for future pre-clinical studies examining the viability of TREN as an option for androgen replacement therapy.


Yarrow JF, Conover CF, McCoy SC, et al. 17β-hydroxyestra-4,9,11-trien-3-one (Trenbolone) Exhibits Tissue Selective Anabolic Activity: Effects on Muscle, Bone, Adiposity, Hemoglobin, and Prostate. American Journal of Physiology - Endocrinology And Metabolism. 17β-hydroxyestra-4,9,11-trien-3-one (Trenbolone) Exhibits Tissue Selective Anabolic Activity: Effects on Muscle, Bone, Adiposity, Hemoglobin, and Prostate — AJP - Endo

Selective androgen receptor modulators (SARMs ) now under development can protect against muscle and bone loss, without causing prostate growth or polycythemia. 17β-hydroxyestra-4,9,11-trien-3-one (trenbolone), a potent testosterone analogue, may have SARM-like actions because, unlike testosterone, trenbolone does not undergo tissue-specific 5α reduction to form more potent androgens. We tested the hypothesis that trenbolone-enanthate (TREN) might prevent orchiectomy-induced losses in muscle and bone and visceral fat accumulation, without increasing prostate mass or resulting in adverse hemoglobin elevations.

Male F344 rats aged three months underwent orchiectomy or remained intact and were administered graded doses of TREN, supraphysiologic testosterone-enanthate, or vehicle for 29 days. In both intact and orchiectomized animals, all TREN doses and supraphysiologic testosterone-enanthate augmented androgen-sensitive levator ani/bulbocavernosus muscle mass by 35-40% above Shams (p≤0.001), and produced a dose-dependent partial protection against orchiectomy-induced total and trabecular bone mineral density losses (p<0.05) and visceral fat accumulation (p<0.05). The lowest doses of TREN successfully maintained prostate mass and hemoglobin concentrations at Sham levels in both intact and orchiectomized animals; whereas supraphysiologic testosterone-enanthate and high-dose TREN elevated prostate mass by 84% and 68%, respectively (p<0.01).

In summary, low dose administration of the non-5α reducible androgen TREN maintains prostate mass and hemoglobin concentrations near the level of Shams, while producing potent myotrophic actions in skeletal muscle and partial protection against orchiectomy-induced bone loss and visceral fat accumulation. Our findings indicate that TREN has advantages over supraphysiologic testosterone and supports the need for future pre-clinical studies examining the viability of TREN as an option for androgen replacement therapy.

cliffs?

[Euroholic]

Haven't heard you in a few, your avi says 23 and I was told you are 18. Are you 18 or 23 ? ...cm

Im 24 you really are crazy hahaha!!!!!